'Old guard' generics players yield U.S. lead to Indian up-and-comers: analyst
admin 18th April 2019 Uncategorised 0What used to be a 12 million prescription advantage the “old guard” generics firms held has been overturned, and the “next six” firms—including a slew of Indian drugmakers—now boast a lead of about 2 million as of the end of March.
More: 'Old guard' generics players yield U.S. lead to Indian up-and-comers: analyst
Source: fierce